Home › NDC Lookup › Ingredients › Dextromethorphan Hbr › 00536-1334-34
Dextromethorphan HBr 15 mg Liquid Gels 15 mg Capsule, Liquid Filled, 20-count — NDC 00536-1334-34 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dextromethorphan HBr 15 mg Liquid Gels 15 mg Capsule, Liquid Filled, 20-count — NDC 0536-1334-34 (Billing 00536-1334-34)

by RUGBY LABORATORIES · 20 CAPSULE, LIQUID FILLED in 1 BOTTLE

This is a package of 20 capsules of Dextromethorphan HBr 15 mg Liquid Gels 15 mg Capsule, Liquid Filled from RUGBY LABORATORIES, marketed since Sep 2021 and currently FDA-listed; retail pharmacies pay about $0.1217 per capsule (NADAC). It is this product's only package size.

NDC 00536-1334-34
🏷️ FDA NDC (as labeled) 0536-1334-34 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0536-1334-34 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1334 product · 34 package
Package marketed since
Sep 4, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
20 EA per package
Barcode (UPC-A, from the NDC)
3 0536133434 5
Medicaid fills, this package
1,312 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1334-34
Product NDC 0536-1334
11-digit billing NDC 00536133434
NCPDP billing unit EA — each (per item)
RxCUI 1090487
UNII 9D2RTI9KYH
Application # M012
SPL Set ID cf3cc387-6642-43fd-999d-688fdaf65d4f
Established class (EPC) Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Mechanism of action Sigma-1 Receptor Agonists; Uncompetitive NMDA Receptor Antagonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-09-04
Route ORAL
Dosage form CAPSULE, LIQUID FILLED
Substance DEXTROMETHORPHAN HYDROBROMIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43102030500110
GPI class Dextromethorphan HBr
GCN Seq No 004622
GCN 17770
HICL code 001925
Ingredient (HICL) Dextromethorphan Hbr
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Midbrain
HIC3 code H6C
Therapeutic class — specific (HIC3) Antitussives, Non-Opioid
AHFS code 48:08.00.00
AHFS class Antitussives
FDB label name DEXTROMETHORPHAN 15 MG SOFTGEL
FDB brand name Dextromethorphan Hbr
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 004622
  • GCN: 17770
  • GPI-14 (Medi-Span): 43102030500110
  • HICL (First Databank): 001925
  • AHFS class code: 48:08.00.00
  • RxCUI (RxNorm): 1090487
Why two NDCs? The FDA registers this code as 0536-1334-34 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1334-34. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name DEXTROMETHORPHAN 15 MG SOFTGEL Ingredient Dextromethorphan Hbr
📖 What it is MedlinePlus · NLM

Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It's a cough suppressant. It temporarily relieves cough from minor throat and bronchial irritation, like with a cold or inhaled irritants. Some products also help you sleep by calm...
  • It depends on the product. Extended-release suspensions like Delsym are labeled for every 12 hours, while Giltuss Honey DM Cough is every 6 to 8 hours with a 4-dose daily limit. Ch...
  • Be careful. Don't use it if you take a prescription MAOI, or within 2 weeks of stopping one. If you're not sure whether your medicine is an MAOI, ask me or your doctor before takin...
  • Nighttime products can cause marked drowsiness, and children may become excitable. Avoid alcohol and be careful driving.
📖 Read our full Dextromethorphan guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.122 $2.43 / 20 capsules
Medicaid paysCMS SDUD · 12 mo $0.2036 $4.07 / 20 capsules
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.122 $0.102
▲ Up 19% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00536-1334-34 You're viewing this Main listing 20 CAPSULE, LIQUID FILLED in 1 BOTTLE 2021-09-04 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Dextromethorphan HBr 15 mg Liquid Gelsthis 00536-1334-34 RUGBY 20 capsules $0.122 — Availability likely —
QUALITY CHOICE Long Acting Cough Softgel 15 mg 83324-0303-20 Chain 20 capsules $0.122 — Availability likely —
Robitussin Long-Acting Coughgels 15 mg 00031-8743-20 Haleon 20 capsules — — FDA listed —
Robitussin Direct Cough 15 mg 00031-9302-01 Haleon 18 capsules — — FDA listed —
Cough Relief 15 mg 00363-8990-20 WALGREEN 20 capsules — — FDA listed —
Cough Suppressant Adult 15 mg 00536-1480-34 Rugby 20 capsules — — FDA listed —
Dextromethorphan Hydrobromide 15 mg 35916-0461-01 Softgel 20 capsules — — FDA listed —
Long Acting Cough Softgels 15 mg 51316-0778-23 CVS 20 capsules — — FDA listed —
CVS Health COUGH SUPPRESSANT SOFTGEL 15 mg 51316-0877-23 CVS 20 capsules — — FDA listed —
Dextromethorphan HBr 15 mg 53345-0011-01 Humanwell 12000 capsules — — FDA listed —
Dextromethorphan HBr 15 mg 53345-0028-01 Humanwell 12000 capsules — — FDA listed —
Right Remedies Adult Long Lasting Cough Relief Softgel 15 mg 70692-0778-06 Strive 60 capsules — — FDA listed —
Gencare Long-Acting Cough Relief 15 mg 72090-0063-01 PIONEER 120 capsules — — FDA listed —
Dextromethorphan Hbr 15 Mg 73629-0005-10 AMZ789 100 capsules — — FDA listed —
Cough Relief 15 mg 80513-0311-06 Advanced 60 capsules — — FDA listed —
ValuMeds Cough Relief, Dextromethorphan Hbr 15 mg 82725-1010-01 Cabinet 120 capsules — — FDA listed —
Goodmeds Non-Drowsy Cough Relief 15 mg 82725-4010-01 Cabinet 120 capsules — — FDA listed —
Goodmeds Cough Relief Dextromethorphan Hbr 15 mg 82725-4110-01 Cabinet 120 capsules — — FDA listed —
Adult Long Lasting Cough Relief 15 mg 83059-0027-01 Shield 15 capsules — — Discontinued —
Adult Long Lasting Cough Relief 15 mg 83059-0110-08 Shield 15 capsules — — Discontinued —
Nuvicare Long-Acting Cough Relief 15 mg 84324-0037-01 NUVICARE 60 capsules — — FDA listed —
Adult Long Lasting Cough Relief 15 mg 83059-0170-01 Shield 15 capsules — — FDA listed —
Dextromethorphan HBr 15 mg 69452-0573-17 BIONPHARMA 60 capsules — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Sep 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color red
ShapeOval
Imprint778
Size13 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Dextromethorphan inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H3R47K3TBD
    FD&C Blue No. 1 is a synthetic blue dye approved for use in foods and medicines. It serves as a colorant to give the medication its distinctive appearance and help with product identification.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII 2G86QN327L
    Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII ND2M416302
    Isopropyl alcohol is a clear liquid solvent derived from petroleum. In medicines, it dissolves active ingredients and other components, helps the product flow smoothly, and aids in sterilization during manufacturing.
  • UNII C9H2L21V7U
    A fat derived from coconut or palm oil containing shorter fatty acid chains. It serves as a solvent and carrier to help dissolve or suspend active ingredients, improving absorption and stability in liquid formulations.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII 8D4SNN7V92
    Propyl gallate is a synthetic antioxidant derived from gallic acid. It prevents oils and fats in the medicine from oxidizing and spoiling, helping the product stay stable and effective during storage.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 6O92ICV9RU
    A waxy substance derived from sorbitol that helps mix oil and water together in medicines. It's used as an emulsifier to keep ingredients evenly blended and stable.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

13 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesedible white ink, FD&C blue #1, FD&C red #40, gelatin, glycerin, isopropyl alcohol, medium chain triglycerides, polyethylene glycol, povidone, propyl gallate, propylene gycol, purified water, sorbitol sorbitan solution

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRUGBY LABORATORIES
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedSep 2021
Product typeHuman Otc Drug
Portfolio149 products on file

More NDCs from RUGBY LABORATORIES labeler code 00536

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 17 words ▾

Use temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.

⏱️ Dosage and Administration 53 words ▾

Directions • do not take more than 8 softgels in any 24-hour period • this adult product is not intended for use in children under 12 years of age adults and children 12 years and older take 2 softgels every 6 to 8 hours, as needed children under 12 years do not use

⚠️ Warnings 175 words ▾

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI)(certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have •a cough that occurs with too much phlegm (mucus) •a cough that lasts or is chronic as occurs with smoking, asthma, or emphysema Stop use and ask a doctor if cough lasts for more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache.

These can be signs of a serious condition. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children.

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

📦 Storage and Handling 16 words ▾

Other information • store at 20°-25°C(68°-77°F) • avoid excessive heat above 40°C(104°F) • protect from light

🧪 Active Ingredient 10 words ▾

Active ingredient (in each softgel) Dextromethorphan HBr, USP 15 mg

🧪 Inactive Ingredients 30 words ▾

Inactive ingredients edible white ink, FD&C blue #1, FD&C red #40, gelatin, glycerin, isopropyl alcohol, medium chain triglycerides, polyethylene glycol, povidone, propyl gallate, propylene gycol, purified water, sorbitol sorbitan solution

🎯 Purpose 3 words ▾

Purpose Cough Suppressant

📄 Keep Out of Reach of Children 45 words ▾

Keep out of reach of children. Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-645-2158

📄 Package Label / Principal Display Panel 2 words ▾

Packaging Dextro1

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.3K
Units reimbursed last 4 qtrs
97K
Gross reimbursed last 4 qtrs
$19.7K
Avg / prescription
$15.05
Avg / unit
$0.2036
Latest quarter Q1 2026
477Rx
Medicaid pays / ea
$0.2036
gross reimbursed
vs
NADAC / ea
$0.1217
acquisition cost
=
Spread
+$0.0819
+67% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
69% FFS 31% MCO
Fee-for-service · 901 Rx Managed care · 411 Rx
State Medicaid map
Alaska: no data reported AK Maine: 5,608 units · 402 per 100k residents ME Washington: 12,106 units · 155 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 6,352 units · 111 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 4,666 units · 39.6 per 100k residents OH Pennsylvania: 687 units · 5.3 per 100k residents PA New Jersey: 601 units · 6.5 per 100k residents NJ Massachusetts: no data reported MA California: 27,925 units · 71.7 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 9,262 units · 149 per 100k residents MO Kentucky: no data reported KY West Virginia: 23,609 units · 1,334 per 100k residents WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 1,946 units · 26.2 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: 3,110 units · 43.6 per 100k residents TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 1,131 units · 3.7 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
3.71,334
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 West Virginia 1,334 /100k
2 Maine 402 /100k
3 Washington 155 /100k
4 Missouri 149 /100k
5 Minnesota 111 /100k
6 California 71.7 /100k
7 Tennessee 43.6 /100k
8 Ohio 39.6 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Dextromethorphan HBr 15 mg Liquid Gels (this brand).

Top reported reactions

Drug Abuse109
Cardiac Arrest21
Completed Suicide21
Respiratory Arrest21
Death16
Toxicity To Various Agents12
Drug Hypersensitivity10

Age at onset

Adult3
Elderly1

Reporter sex

213 reports
Male · 57%
Female · 43%
Unknown · 0%

Serious outcomes

Death144
Hospitalization28
Life-threatening3
Disabling3
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 00536-1333-21 · RUGBY 00536-1337-09 · Rugby →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.